Jiao Ji

Title: Jiao Ji - Innovator in Cancer Treatment

Introduction

Jiao Ji is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of biomedicine, particularly in cancer treatment. His innovative approach combines various therapeutic agents to enhance treatment efficacy.

Latest Patents

Jiao Ji holds a patent for a method for treating cancer by the combination of an IAP inhibitor and a modulator of an immune checkpoint molecule. This method aims to treat, suppress, reduce the severity of, lower the risk of, or inhibit the metastasis of cancer in individuals. The patent also includes the administration of a therapeutically effective amount of a tubulin inhibitor, along with the other agents. This innovative method represents a significant advancement in cancer therapy.

Career Highlights

Jiao Ji is associated with Ascentage Pharma (Suzhou) Co., Ltd., where he continues to work on groundbreaking research in cancer treatment. His dedication to improving patient outcomes through innovative therapies is commendable. He has been instrumental in developing new methods that could potentially change the landscape of cancer treatment.

Collaborations

Jiao Ji collaborates with notable colleagues, including Dajun Yang and Yifan Zhai. Their combined expertise fosters a productive research environment, leading to advancements in biomedicine.

Conclusion

Jiao Ji's contributions to cancer treatment through his innovative patent highlight his role as a leading inventor in the field. His work at Ascentage Pharma continues to pave the way for new therapeutic strategies in combating cancer.